Compare KE & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KE | CTKB |
|---|---|---|
| Founded | 1961 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 635.4M | 595.2M |
| IPO Year | 2014 | 2021 |
| Metric | KE | CTKB |
|---|---|---|
| Price | $24.58 | $3.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $28.00 | $5.63 |
| AVG Volume (30 Days) | 128.5K | ★ 932.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $1,486,727,000.00 | $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | $4.57 | $7.03 |
| P/E Ratio | $31.13 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $17.56 | $2.43 |
| 52 Week High | $33.19 | $6.18 |
| Indicator | KE | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 45.61 |
| Support Level | $23.49 | $3.30 |
| Resistance Level | $26.92 | $4.26 |
| Average True Range (ATR) | 1.14 | 0.30 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 29.48 | 40.77 |
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.